Cargando…

The value of subtraction MRI in detection of amyloid-related imaging abnormalities with oedema or effusion in Alzheimer’s patients: An interobserver study

BACKGROUND: Immunotherapeutic treatments targeting amyloid-β plaques in Alzheimer’s disease (AD) are associated with the presence of amyloid-related imaging abnormalities with oedema or effusion (ARIA-E), whose detection and classification is crucial to evaluate subjects enrolled in clinical trials....

Descripción completa

Detalles Bibliográficos
Autores principales: Martens, Roland M., Bechten, Arianne, Ingala, Silvia, van Schijndel, Ronald A., Machado, Vania B., de Jong, Marcus C., Sanchez, Esther, Purcell, Derk, Arrighi, Michael H., Brashear, Robert H., Wattjes, Mike P., Barkhof, Frederik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811582/
https://www.ncbi.nlm.nih.gov/pubmed/28956123
http://dx.doi.org/10.1007/s00330-017-5022-6
_version_ 1783299889852055552
author Martens, Roland M.
Bechten, Arianne
Ingala, Silvia
van Schijndel, Ronald A.
Machado, Vania B.
de Jong, Marcus C.
Sanchez, Esther
Purcell, Derk
Arrighi, Michael H.
Brashear, Robert H.
Wattjes, Mike P.
Barkhof, Frederik
author_facet Martens, Roland M.
Bechten, Arianne
Ingala, Silvia
van Schijndel, Ronald A.
Machado, Vania B.
de Jong, Marcus C.
Sanchez, Esther
Purcell, Derk
Arrighi, Michael H.
Brashear, Robert H.
Wattjes, Mike P.
Barkhof, Frederik
author_sort Martens, Roland M.
collection PubMed
description BACKGROUND: Immunotherapeutic treatments targeting amyloid-β plaques in Alzheimer’s disease (AD) are associated with the presence of amyloid-related imaging abnormalities with oedema or effusion (ARIA-E), whose detection and classification is crucial to evaluate subjects enrolled in clinical trials. PURPOSE: To investigate the applicability of subtraction MRI in the ARIA-E detection using an established ARIA-E-rating scale. METHODS: We included 75 AD patients receiving bapineuzumab treatment, including 29 ARIA-E cases. Five neuroradiologists rated their brain MRI-scans with and without subtraction images. The accuracy of evaluating the presence of ARIA-E, intraclass correlation coefficient (ICC) and specific agreement was calculated. RESULTS: Subtraction resulted in higher sensitivity (0.966) and lower specificity (0.970) than native images (0.959, 0.991, respectively). Individual rater detection was excellent. ICC scores ranged from excellent to good, except for gyral swelling (moderate). Excellent negative and good positive specific agreement among all ARIA-E imaging features was reported in both groups. Combining sulcal hyperintensity and gyral swelling significantly increased positive agreement for subtraction images. CONCLUSION: Subtraction MRI has potential as a visual aid increasing the sensitivity of ARIA-E assessment. However, in order to improve its usefulness isotropic acquisition and enhanced training are required. The ARIA-E rating scale may benefit from combining sulcal hyperintensity and swelling. KEY POINTS: • Subtraction technique can improve detection amyloid-related imaging-abnormalities with edema/effusion in Alzheimer’s patients. • The value of ARIA-E detection, classification and monitoring using subtraction was assessed. • Validation of an established ARIA-E rating scale, recommendations for improvement are reported. • Complementary statistical methods were employed to measure accuracy, inter-rater-reliability and specific agreement.
format Online
Article
Text
id pubmed-5811582
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-58115822018-02-23 The value of subtraction MRI in detection of amyloid-related imaging abnormalities with oedema or effusion in Alzheimer’s patients: An interobserver study Martens, Roland M. Bechten, Arianne Ingala, Silvia van Schijndel, Ronald A. Machado, Vania B. de Jong, Marcus C. Sanchez, Esther Purcell, Derk Arrighi, Michael H. Brashear, Robert H. Wattjes, Mike P. Barkhof, Frederik Eur Radiol Neuro BACKGROUND: Immunotherapeutic treatments targeting amyloid-β plaques in Alzheimer’s disease (AD) are associated with the presence of amyloid-related imaging abnormalities with oedema or effusion (ARIA-E), whose detection and classification is crucial to evaluate subjects enrolled in clinical trials. PURPOSE: To investigate the applicability of subtraction MRI in the ARIA-E detection using an established ARIA-E-rating scale. METHODS: We included 75 AD patients receiving bapineuzumab treatment, including 29 ARIA-E cases. Five neuroradiologists rated their brain MRI-scans with and without subtraction images. The accuracy of evaluating the presence of ARIA-E, intraclass correlation coefficient (ICC) and specific agreement was calculated. RESULTS: Subtraction resulted in higher sensitivity (0.966) and lower specificity (0.970) than native images (0.959, 0.991, respectively). Individual rater detection was excellent. ICC scores ranged from excellent to good, except for gyral swelling (moderate). Excellent negative and good positive specific agreement among all ARIA-E imaging features was reported in both groups. Combining sulcal hyperintensity and gyral swelling significantly increased positive agreement for subtraction images. CONCLUSION: Subtraction MRI has potential as a visual aid increasing the sensitivity of ARIA-E assessment. However, in order to improve its usefulness isotropic acquisition and enhanced training are required. The ARIA-E rating scale may benefit from combining sulcal hyperintensity and swelling. KEY POINTS: • Subtraction technique can improve detection amyloid-related imaging-abnormalities with edema/effusion in Alzheimer’s patients. • The value of ARIA-E detection, classification and monitoring using subtraction was assessed. • Validation of an established ARIA-E rating scale, recommendations for improvement are reported. • Complementary statistical methods were employed to measure accuracy, inter-rater-reliability and specific agreement. Springer Berlin Heidelberg 2017-09-27 2018 /pmc/articles/PMC5811582/ /pubmed/28956123 http://dx.doi.org/10.1007/s00330-017-5022-6 Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Neuro
Martens, Roland M.
Bechten, Arianne
Ingala, Silvia
van Schijndel, Ronald A.
Machado, Vania B.
de Jong, Marcus C.
Sanchez, Esther
Purcell, Derk
Arrighi, Michael H.
Brashear, Robert H.
Wattjes, Mike P.
Barkhof, Frederik
The value of subtraction MRI in detection of amyloid-related imaging abnormalities with oedema or effusion in Alzheimer’s patients: An interobserver study
title The value of subtraction MRI in detection of amyloid-related imaging abnormalities with oedema or effusion in Alzheimer’s patients: An interobserver study
title_full The value of subtraction MRI in detection of amyloid-related imaging abnormalities with oedema or effusion in Alzheimer’s patients: An interobserver study
title_fullStr The value of subtraction MRI in detection of amyloid-related imaging abnormalities with oedema or effusion in Alzheimer’s patients: An interobserver study
title_full_unstemmed The value of subtraction MRI in detection of amyloid-related imaging abnormalities with oedema or effusion in Alzheimer’s patients: An interobserver study
title_short The value of subtraction MRI in detection of amyloid-related imaging abnormalities with oedema or effusion in Alzheimer’s patients: An interobserver study
title_sort value of subtraction mri in detection of amyloid-related imaging abnormalities with oedema or effusion in alzheimer’s patients: an interobserver study
topic Neuro
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811582/
https://www.ncbi.nlm.nih.gov/pubmed/28956123
http://dx.doi.org/10.1007/s00330-017-5022-6
work_keys_str_mv AT martensrolandm thevalueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy
AT bechtenarianne thevalueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy
AT ingalasilvia thevalueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy
AT vanschijndelronalda thevalueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy
AT machadovaniab thevalueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy
AT dejongmarcusc thevalueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy
AT sanchezesther thevalueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy
AT purcellderk thevalueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy
AT arrighimichaelh thevalueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy
AT brashearroberth thevalueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy
AT wattjesmikep thevalueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy
AT barkhoffrederik thevalueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy
AT martensrolandm valueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy
AT bechtenarianne valueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy
AT ingalasilvia valueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy
AT vanschijndelronalda valueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy
AT machadovaniab valueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy
AT dejongmarcusc valueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy
AT sanchezesther valueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy
AT purcellderk valueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy
AT arrighimichaelh valueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy
AT brashearroberth valueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy
AT wattjesmikep valueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy
AT barkhoffrederik valueofsubtractionmriindetectionofamyloidrelatedimagingabnormalitieswithoedemaoreffusioninalzheimerspatientsaninterobserverstudy